Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults [Phase 3]

View source ↗

Summary

Phase 3 study comparing Bictegravir/Emtricitabine/Tenofovir Alafenamide to Abacavir/Dolutegravir/Lamivudine in ART-naive HIV-1 adults; completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Abacavir/dolutegravir/lamivudine
• Bictegravir/Emtricitabine/Tenofovir Alafenamide (Bictegravir/emtricitabine/tenofovir alafenamide)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1 Infection | Phase 3 | Status: COMPLETED | Results posted: 2018-07-23